| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 26 | 2025 | 755 | 7.570 |
Why?
|
| Virus Integration | 12 | 2025 | 65 | 5.350 |
Why?
|
| HIV Infections | 20 | 2025 | 2586 | 3.610 |
Why?
|
| DNA, Viral | 12 | 2025 | 311 | 3.100 |
Why?
|
| Virus Replication | 10 | 2024 | 318 | 2.050 |
Why?
|
| Cocaine | 8 | 2021 | 251 | 2.020 |
Why?
|
| MicroRNAs | 10 | 2021 | 518 | 1.850 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2015 | 279 | 1.830 |
Why?
|
| Cyclophilin A | 2 | 2024 | 19 | 1.690 |
Why?
|
| Exodeoxyribonucleases | 2 | 2024 | 17 | 1.560 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 2 | 2025 | 21 | 1.520 |
Why?
|
| Capsid Proteins | 4 | 2024 | 76 | 1.380 |
Why?
|
| Phosphoproteins | 2 | 2024 | 206 | 1.370 |
Why?
|
| Capsid | 4 | 2024 | 65 | 1.160 |
Why?
|
| HIV Reverse Transcriptase | 6 | 2011 | 35 | 1.070 |
Why?
|
| Chromatin | 2 | 2025 | 186 | 0.990 |
Why?
|
| Nucleosomes | 2 | 2025 | 30 | 0.990 |
Why?
|
| Retroviridae | 1 | 2025 | 25 | 0.920 |
Why?
|
| Methamphetamine | 3 | 2021 | 166 | 0.890 |
Why?
|
| Plant Diseases | 5 | 2020 | 65 | 0.890 |
Why?
|
| Histones | 2 | 2025 | 197 | 0.890 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 226 | 0.880 |
Why?
|
| HIV Seropositivity | 2 | 2023 | 196 | 0.860 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 91 | 0.820 |
Why?
|
| Humans | 43 | 2025 | 43102 | 0.810 |
Why?
|
| Host-Pathogen Interactions | 5 | 2023 | 209 | 0.810 |
Why?
|
| Dipeptidases | 2 | 2023 | 9 | 0.800 |
Why?
|
| Histone Code | 1 | 2022 | 13 | 0.760 |
Why?
|
| Down-Regulation | 4 | 2020 | 456 | 0.750 |
Why?
|
| Chromosomes, Human | 1 | 2022 | 37 | 0.740 |
Why?
|
| Hemiptera | 5 | 2020 | 10 | 0.730 |
Why?
|
| Hypocreales | 2 | 2018 | 3 | 0.710 |
Why?
|
| RNA, Viral | 3 | 2019 | 321 | 0.710 |
Why?
|
| HIV Integrase | 2 | 2022 | 22 | 0.700 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 166 | 0.680 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 82 | 0.660 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1070 | 0.660 |
Why?
|
| Immunity, Innate | 1 | 2021 | 171 | 0.650 |
Why?
|
| Disease Progression | 4 | 2015 | 667 | 0.620 |
Why?
|
| Phenylalanine | 2 | 2019 | 25 | 0.610 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2021 | 69 | 0.590 |
Why?
|
| Tetranychidae | 1 | 2018 | 1 | 0.580 |
Why?
|
| Microvessels | 1 | 2019 | 31 | 0.580 |
Why?
|
| Microbial Interactions | 1 | 2018 | 11 | 0.580 |
Why?
|
| Phaseolus | 1 | 2018 | 20 | 0.570 |
Why?
|
| RNA Interference | 2 | 2021 | 247 | 0.550 |
Why?
|
| Cell Nucleus | 4 | 2023 | 383 | 0.540 |
Why?
|
| Indoles | 1 | 2019 | 187 | 0.530 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 83 | 0.520 |
Why?
|
| Ribonuclease H | 5 | 2008 | 11 | 0.520 |
Why?
|
| Hypertension | 1 | 2024 | 835 | 0.520 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 173 | 0.520 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 102 | 0.500 |
Why?
|
| Proline Oxidase | 1 | 2015 | 11 | 0.470 |
Why?
|
| Endothelial Cells | 1 | 2019 | 329 | 0.470 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 54 | 0.460 |
Why?
|
| Semen | 3 | 2021 | 57 | 0.450 |
Why?
|
| DNA | 3 | 2008 | 592 | 0.450 |
Why?
|
| DNA Primers | 5 | 2012 | 294 | 0.450 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 458 | 0.450 |
Why?
|
| Citrus | 3 | 2020 | 14 | 0.440 |
Why?
|
| Pest Control, Biological | 3 | 2018 | 9 | 0.430 |
Why?
|
| Animals | 22 | 2025 | 16992 | 0.430 |
Why?
|
| Purines | 2 | 2004 | 40 | 0.420 |
Why?
|
| Autophagy | 1 | 2015 | 140 | 0.420 |
Why?
|
| Adrenergic Agents | 1 | 2013 | 8 | 0.410 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2011 | 57 | 0.410 |
Why?
|
| Reverse Transcription | 3 | 2024 | 23 | 0.390 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2003 | 19 | 0.380 |
Why?
|
| Protein Binding | 8 | 2024 | 1082 | 0.360 |
Why?
|
| Cytidine Deaminase | 1 | 2011 | 36 | 0.350 |
Why?
|
| Anti-HIV Agents | 2 | 2019 | 486 | 0.350 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 23 | 0.350 |
Why?
|
| Dinucleoside Phosphates | 1 | 2011 | 11 | 0.350 |
Why?
|
| Proline | 2 | 2021 | 40 | 0.340 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 67 | 0.340 |
Why?
|
| RNA-Directed DNA Polymerase | 2 | 2012 | 17 | 0.330 |
Why?
|
| Proviruses | 2 | 2024 | 35 | 0.330 |
Why?
|
| Prostate | 1 | 2011 | 155 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 165 | 0.330 |
Why?
|
| Kinetics | 6 | 2024 | 695 | 0.320 |
Why?
|
| Mycotoxins | 2 | 2020 | 12 | 0.310 |
Why?
|
| Cordyceps | 2 | 2020 | 4 | 0.310 |
Why?
|
| Templates, Genetic | 2 | 2006 | 23 | 0.300 |
Why?
|
| Proteome | 2 | 2021 | 152 | 0.300 |
Why?
|
| Neurons | 2 | 2021 | 1263 | 0.300 |
Why?
|
| Nucleosides | 2 | 2006 | 30 | 0.300 |
Why?
|
| RNA | 2 | 2008 | 266 | 0.290 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 291 | 0.290 |
Why?
|
| Apoptosis | 3 | 2021 | 1568 | 0.280 |
Why?
|
| Rhizobiaceae | 2 | 2018 | 4 | 0.280 |
Why?
|
| Ascomycota | 2 | 2018 | 21 | 0.280 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 2676 | 0.280 |
Why?
|
| Monocytes | 2 | 2021 | 277 | 0.280 |
Why?
|
| Models, Chemical | 3 | 2008 | 204 | 0.260 |
Why?
|
| Nucleotides | 1 | 2006 | 37 | 0.250 |
Why?
|
| Exosomes | 2 | 2019 | 126 | 0.250 |
Why?
|
| Protease Inhibitors | 2 | 2003 | 54 | 0.240 |
Why?
|
| Models, Molecular | 5 | 2018 | 876 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2018 | 1271 | 0.240 |
Why?
|
| alpha-Crystallins | 1 | 2005 | 2 | 0.230 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1455 | 0.230 |
Why?
|
| HIV Protease | 1 | 2005 | 23 | 0.230 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 1092 | 0.230 |
Why?
|
| Mutation | 4 | 2020 | 1177 | 0.230 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 110 | 0.220 |
Why?
|
| Cyclosporine | 1 | 2024 | 36 | 0.220 |
Why?
|
| Polyadenylation | 1 | 2025 | 49 | 0.220 |
Why?
|
| Nucleic Acid Probes | 1 | 2004 | 1 | 0.210 |
Why?
|
| Protein Folding | 1 | 2005 | 123 | 0.210 |
Why?
|
| Virion | 2 | 2015 | 75 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2004 | 25 | 0.210 |
Why?
|
| Cytosine | 1 | 2004 | 33 | 0.210 |
Why?
|
| Sp1 Transcription Factor | 1 | 2023 | 46 | 0.200 |
Why?
|
| Base Sequence | 5 | 2021 | 983 | 0.200 |
Why?
|
| Binding Sites | 4 | 2020 | 671 | 0.200 |
Why?
|
| Tennessee | 1 | 2023 | 93 | 0.200 |
Why?
|
| Thermodynamics | 1 | 2024 | 229 | 0.200 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.190 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 830 | 0.190 |
Why?
|
| Methylation | 1 | 2022 | 119 | 0.190 |
Why?
|
| Xylosidases | 1 | 2002 | 1 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1124 | 0.180 |
Why?
|
| Calcium | 1 | 2005 | 491 | 0.180 |
Why?
|
| Plant Stems | 2 | 2018 | 12 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2018 | 1621 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 119 | 0.180 |
Why?
|
| Viral Proteins | 1 | 2023 | 190 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2018 | 434 | 0.180 |
Why?
|
| Chemotaxis | 1 | 2021 | 68 | 0.180 |
Why?
|
| Temperature | 2 | 2018 | 313 | 0.170 |
Why?
|
| Schools | 1 | 2023 | 283 | 0.170 |
Why?
|
| Insecticides | 2 | 2018 | 54 | 0.170 |
Why?
|
| Drug Design | 1 | 2003 | 186 | 0.170 |
Why?
|
| Larva | 2 | 2018 | 133 | 0.170 |
Why?
|
| Mice | 8 | 2025 | 6644 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2015 | 536 | 0.170 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 206 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2017 | 462 | 0.160 |
Why?
|
| Hela Cells | 1 | 2021 | 376 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2021 | 131 | 0.160 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.160 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1542 | 0.160 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 100 | 0.150 |
Why?
|
| Homeostasis | 1 | 2021 | 192 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2023 | 2157 | 0.150 |
Why?
|
| Plant Roots | 2 | 2018 | 180 | 0.150 |
Why?
|
| Molecular Structure | 3 | 2018 | 570 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 306 | 0.150 |
Why?
|
| Isoptera | 1 | 2018 | 5 | 0.140 |
Why?
|
| Antibiosis | 1 | 2018 | 6 | 0.140 |
Why?
|
| Metarhizium | 1 | 2018 | 4 | 0.140 |
Why?
|
| Fertility | 1 | 2018 | 62 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2019 | 128 | 0.140 |
Why?
|
| Citrus sinensis | 1 | 2018 | 4 | 0.140 |
Why?
|
| Biotin | 1 | 2018 | 24 | 0.140 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 30 | 0.140 |
Why?
|
| HIV | 1 | 2018 | 100 | 0.140 |
Why?
|
| Moths | 1 | 2018 | 11 | 0.140 |
Why?
|
| Virus Internalization | 1 | 2018 | 36 | 0.140 |
Why?
|
| Protein Conformation | 4 | 2018 | 416 | 0.140 |
Why?
|
| Porphyromonas gingivalis | 1 | 2018 | 40 | 0.140 |
Why?
|
| Plant Leaves | 1 | 2018 | 136 | 0.140 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 29 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 1001 | 0.140 |
Why?
|
| Insect Proteins | 1 | 2018 | 53 | 0.130 |
Why?
|
| Halomonadaceae | 1 | 2017 | 1 | 0.130 |
Why?
|
| Wolbachia | 1 | 2017 | 4 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2018 | 368 | 0.130 |
Why?
|
| Students | 1 | 2023 | 626 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 160 | 0.130 |
Why?
|
| Plants | 1 | 2018 | 113 | 0.130 |
Why?
|
| Phylogeny | 2 | 2018 | 769 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 189 | 0.130 |
Why?
|
| Symbiosis | 1 | 2017 | 46 | 0.130 |
Why?
|
| Salicylates | 1 | 2017 | 9 | 0.130 |
Why?
|
| Nucleoproteins | 1 | 2017 | 15 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 378 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 595 | 0.130 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 21 | 0.130 |
Why?
|
| Cryopreservation | 1 | 2017 | 39 | 0.130 |
Why?
|
| Menthol | 1 | 2017 | 23 | 0.130 |
Why?
|
| Cytoplasm | 1 | 2017 | 154 | 0.120 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 592 | 0.120 |
Why?
|
| Genome, Viral | 1 | 2017 | 119 | 0.120 |
Why?
|
| Substrate Specificity | 3 | 2012 | 219 | 0.120 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2015 | 12 | 0.120 |
Why?
|
| Arabidopsis | 1 | 2017 | 103 | 0.120 |
Why?
|
| Risk Factors | 1 | 2024 | 3994 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 51 | 0.120 |
Why?
|
| Doxycycline | 1 | 2015 | 32 | 0.120 |
Why?
|
| Vesiculovirus | 1 | 2015 | 5 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 1180 | 0.110 |
Why?
|
| Phytohemagglutinins | 1 | 2015 | 13 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2018 | 430 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 95 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 968 | 0.110 |
Why?
|
| Endometrium | 1 | 2015 | 59 | 0.110 |
Why?
|
| Endocytosis | 1 | 2015 | 118 | 0.110 |
Why?
|
| Male | 8 | 2025 | 23409 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 249 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 457 | 0.100 |
Why?
|
| Cell Separation | 1 | 2014 | 94 | 0.100 |
Why?
|
| Viral Load | 1 | 2015 | 348 | 0.100 |
Why?
|
| China | 3 | 2018 | 229 | 0.100 |
Why?
|
| Avian myeloblastosis virus | 1 | 2012 | 5 | 0.100 |
Why?
|
| GC Rich Sequence | 1 | 2012 | 3 | 0.100 |
Why?
|
| Moloney murine leukemia virus | 1 | 2012 | 7 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 411 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 532 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1019 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 310 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 432 | 0.090 |
Why?
|
| Metalloproteases | 1 | 2011 | 18 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 197 | 0.090 |
Why?
|
| Mitochondria | 1 | 2015 | 523 | 0.090 |
Why?
|
| Virus Latency | 1 | 2010 | 49 | 0.080 |
Why?
|
| Hot Temperature | 2 | 2017 | 141 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 290 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 280 | 0.080 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 74 | 0.080 |
Why?
|
| Nymph | 2 | 2020 | 3 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 883 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 1472 | 0.070 |
Why?
|
| Dimerization | 2 | 2008 | 112 | 0.070 |
Why?
|
| DNA Footprinting | 1 | 2008 | 8 | 0.070 |
Why?
|
| Organophosphorus Compounds | 1 | 2008 | 37 | 0.070 |
Why?
|
| Gene Expression | 1 | 2011 | 701 | 0.070 |
Why?
|
| Fermentation | 2 | 2018 | 39 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 31 | 0.070 |
Why?
|
| Molecular Weight | 2 | 2018 | 168 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 55 | 0.070 |
Why?
|
| Catalysis | 2 | 2005 | 187 | 0.070 |
Why?
|
| Spores, Fungal | 2 | 2018 | 21 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 1596 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2008 | 104 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 173 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 203 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 70 | 0.060 |
Why?
|
| Protein Renaturation | 1 | 2005 | 2 | 0.060 |
Why?
|
| Furans | 1 | 2005 | 40 | 0.060 |
Why?
|
| Cations, Divalent | 1 | 2005 | 25 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2005 | 41 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 291 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 1772 | 0.060 |
Why?
|
| Nucleic Acid Conformation | 1 | 2005 | 154 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2003 | 184 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 70 | 0.050 |
Why?
|
| Potassium Permanganate | 1 | 2004 | 1 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 81 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 182 | 0.050 |
Why?
|
| Thymine | 1 | 2004 | 25 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2004 | 64 | 0.050 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2004 | 4 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2004 | 97 | 0.050 |
Why?
|
| Base Pairing | 1 | 2004 | 41 | 0.050 |
Why?
|
| Adenine | 1 | 2004 | 46 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 5080 | 0.050 |
Why?
|
| Endopeptidase K | 1 | 2003 | 4 | 0.050 |
Why?
|
| Guanine | 1 | 2004 | 44 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 144 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 665 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 436 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 423 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 97 | 0.050 |
Why?
|
| Oxygen | 1 | 2004 | 218 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2003 | 35 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 182 | 0.050 |
Why?
|
| HIV Protease Inhibitors | 1 | 2003 | 24 | 0.050 |
Why?
|
| Collagen | 1 | 2023 | 181 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 44 | 0.050 |
Why?
|
| Stearic Acids | 1 | 2002 | 7 | 0.050 |
Why?
|
| Enzymes, Immobilized | 1 | 2002 | 13 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 216 | 0.050 |
Why?
|
| Xylan Endo-1,3-beta-Xylosidase | 1 | 2002 | 1 | 0.050 |
Why?
|
| o-Phthalaldehyde | 1 | 2002 | 4 | 0.050 |
Why?
|
| Actinomycetales | 1 | 2002 | 5 | 0.050 |
Why?
|
| Bacillus | 1 | 2002 | 12 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2002 | 64 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2018 | 83 | 0.050 |
Why?
|
| Isomerism | 1 | 2002 | 64 | 0.050 |
Why?
|
| Fungi | 1 | 2002 | 106 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 46 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2021 | 17 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 74 | 0.040 |
Why?
|
| Cricetulus | 1 | 2021 | 82 | 0.040 |
Why?
|
| CHO Cells | 1 | 2021 | 123 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 149 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 155 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 60 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 278 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 506 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 151 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 246 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 184 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 12222 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 220 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 737 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2023 | 735 | 0.040 |
Why?
|
| Sorghum | 1 | 2018 | 3 | 0.040 |
Why?
|
| Beauveria | 1 | 2018 | 4 | 0.040 |
Why?
|
| AIDS Vaccines | 1 | 2018 | 26 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 2018 | 56 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 749 | 0.040 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2018 | 10 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 13872 | 0.040 |
Why?
|
| Pakistan | 1 | 2018 | 20 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 51 | 0.040 |
Why?
|
| Genes, Insect | 1 | 2018 | 27 | 0.040 |
Why?
|
| Insect Vectors | 1 | 2018 | 27 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2018 | 67 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2018 | 62 | 0.030 |
Why?
|
| India | 1 | 2018 | 108 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|
| Metabolomics | 1 | 2018 | 95 | 0.030 |
Why?
|
| Soil Microbiology | 1 | 2018 | 68 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 84 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2017 | 27 | 0.030 |
Why?
|
| Haplotypes | 1 | 2018 | 197 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 6081 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 59 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 140 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2017 | 8 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 92 | 0.030 |
Why?
|
| Aphids | 1 | 2017 | 1 | 0.030 |
Why?
|
| Transfection | 1 | 2018 | 532 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 341 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 678 | 0.030 |
Why?
|
| Hyphae | 1 | 2017 | 36 | 0.030 |
Why?
|
| Soil | 1 | 2018 | 171 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 388 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2018 | 232 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2017 | 136 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 498 | 0.030 |
Why?
|
| Metrorrhagia | 1 | 2015 | 8 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 465 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 234 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2853 | 0.030 |
Why?
|
| Female | 2 | 2015 | 24698 | 0.030 |
Why?
|
| Retroelements | 1 | 2012 | 14 | 0.020 |
Why?
|
| United States | 1 | 2023 | 5205 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1869 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1600 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3735 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 8214 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2008 | 11 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 99 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2008 | 45 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2008 | 118 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 155 | 0.020 |
Why?
|
| Genome | 1 | 2008 | 149 | 0.020 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2006 | 17 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 135 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2008 | 460 | 0.010 |
Why?
|
| DNA Replication | 1 | 2006 | 148 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 638 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 515 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 704 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2003 | 29 | 0.010 |
Why?
|
| Diffusion | 1 | 2002 | 63 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 33 | 0.010 |
Why?
|
| Drug Stability | 1 | 2002 | 129 | 0.010 |
Why?
|